Back
Lifecore Biomedical, Inc. 10K Form
Sell
48
LFCR
Lifecore Biomedical, Inc.
Last Price:
$7.78
Seasonality Move:
2.06%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LFCR News And Ratings
See the #1 stock for the next 7 days that we like better than LFCR
LFCR Financial Statistics
Sales & Book Value
| Annual Sales: | $128.9M |
|---|---|
| Cash Flow: | $25K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.28 |
| Price / Book: | 192.11 |
Profitability
| EPS (TTM): | -1.06980 |
|---|---|
| Net Income (TTM): | $-32.5M |
| Gross Margin: | $40.3M |
| Return on Equity: | -70.33% |
| Return on Assets: | -13.37% |
Lifecore Biomedical, Inc. Earnings Forecast
Key Lifecore Biomedical, Inc. Financial Ratios
-
The Gross Profit Margin over the past 30 years for LFCR is 31.27%.
-
The Selling, General & Administrative Expenses for LFCR have been equal to 34.18% of Gross Profit Margin.
-
The Research & Development expenses have been 6.41% of Revenue.
-
The Net Earning history of LFCR is -30.04% of Total Revenues.
-
Per Share Earnings over the last 30 years have been positive in 15 years.
Lifecore Biomedical, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | LFCR |
| Website: | lifecore.com |
Debt
| Debt-to-Equity Ratio: | 3.74 |
|---|---|
| Current Ratio: | 2.8 |
| Quick Ratio: | 1.63 |
Price-to-Earnings
| Trailing P/E Ratio: | 22.63 |
|---|---|
| Forward P/E Ratio: | 0 |
LFCR Technical Analysis vs Fundamental Analysis
Sell
48
Lifecore Biomedical, Inc. (LFCR)
is a Sell
Is Lifecore Biomedical, Inc. a Buy or a Sell?
-
Lifecore Biomedical, Inc. stock is rated a SellThe current Lifecore Biomedical, Inc. [LFCR] share price is $7.77. The Score for LFCR is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.